Skip to main content
Home

Main navigation

  • Tentang HIPRA

      Tentang HIPRA

    • Jelajahi HIPRA
    • Sejarah
    • Keberlanjutan & CSR
    • HIPRA di seluruh dunia
  • Kesehatan Hewan

      Kesehatan Hewan

    • Produk kami
      • Vaksin
      • Perlengkapan Diagnosa
      • Farmasi
    • Jasa kami
      • About Smart Vaccination
      • HIPRASTATS
      • HIPRA Diagnos
      • HIPRA University
      • Kalkulator online
    • Pengetahuan
    • Berita
    • Solusi
      • Babi
      • Unggas
      • Ternak
      • Domba dan kambing
      • Kelinci
      • Ikan
      • Anjing
  • Kesehatan Manusia

      Kesehatan Manusia

    • Produk kami
      • COVID-19
      • Kesehatan pencernaan (GoodGut)
    • Proyek penelitian & pengembangan
    • Berita
    • Pers
  • Karier
  • Hubungi kami
Career
Search
Search

Pers

who we are
Pers
01/17/2023 - 14:29

HIPRA’s COVID-19 vaccine trial in people with immunocompromising conditions was launched in Turkey

Manusia
Jelajahi
11/07/2022 - 17:20

HIPRA starts a clinical trial to study its vaccine against COVID-19 as a 4th dose

Manusia
Jelajahi
07/19/2022 - 10:14

HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the BA.2, BA.4 and BA.5 subvariants of Omicron

Manusia
Jelajahi
05/18/2022 - 10:13

HIPRA initiates the first Phase III clinical trial of Covid-19 vaccine in immunocompromised people

Manusia
Jelajahi
03/29/2022 - 14:02

EMA starts rolling review of Covid-19 HIPRA’s vaccine

Manusia
Jelajahi
03/16/2022 - 08:45

GoodGut and Vall d'Hebron Barcelona Hospital are studying the implementation of the first non-invasive diagnostic test to detect Irritable Bowel Syndrome

Manusia
Jelajahi
  • Load More
Home

Footer second

  • Tentang HIPRA
  • Kesehatan Hewan
  • Kesehatan Manusia

Footer third

  • Karier
  • Hubungi kami

Footer fourth

  • LinkedIn
  • YouTube

Footer

  • Ketentuan Penggunaan
  • Kebijakan Privasi
  • Kebijakan Cookie